Sarah Fortune on what’s next in the fight against tuberculosis
Sarah Fortune, our resident Tuberculosis expert on vaccines was on the panel of Combatting a global killer: What’s next in the fight against tuberculosis.
Sarah Fortune, our resident Tuberculosis expert on vaccines was on the panel of Combatting a global killer: What’s next in the fight against tuberculosis.
With TB being such a multi-faceted disease, what aspect does your research focus on? My research is focused on understanding how Mycobacterium tuberculosis (M. tuberculosis) evolves to evade antibiotic killing in … Continue reading “Q&A with Qingyun Liu”
With TB being such a multi-faceted disease, what aspect does your research focus on? My work focuses on how we can use a two-headed targeted degrader molecule to redirect Mtb’s … Continue reading “Q&A with Harim Won”
Jeremy M. Rock, Ph.D. Penrhyn E. Cook Assistant Professor The Rockefeller University
For immediate release: December 8, 2022 Boston, MA – Researchers have discovered a new form of altered drug susceptibility—dubbed antibiotic resilience—that enables Mycobacterium tuberculosis (Mtb) to survive antibiotic treatment. The study, led … Continue reading “Failure of tuberculosis treatment linked to bacterial resilience”
May 12, 2022 – Over the past few years of his PhD research, Harim Won has been laying the groundwork to develop a new type of antibiotic to treat tuberculosis (TB), … Continue reading “A better antibiotic for tuberculosis treatment”